90
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Editorial

Pages 193-197 | Published online: 09 Jul 2009

References

  • Wiggenraad R, Koning C, Westerman C, Jansen C, van der Zee J. Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma. International Journal of Hyperthermia 2005; in press.
  • Hall EJ. Do no harm. Normal tissue effects. Acta Oncologica 2001;40:913–916.
  • Maduro JH, Pras E, Willemse PHB, de Vries EGE. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treatment Review 2003;29:471–488.
  • Brenner DJ. Fractionation and late rectal toxicity. International Journal of Radiation Oncology, Biology & Physics 2004;60:1013–1015.
  • Borris C, Bares JP, Rudder D, Amer A, Mil16n F, Abushaibe 0. Clinical effects in a cohort of cancer patients overexposed during external beam pelvic radiotherapy. International Journal of Radiation Oncology, Biology & Physics 2004;59:538–550.
  • Dahl 0, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavii H, Thunold J. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer 1990;66:2286–2294.
  • Dahl 0, Horn A, Mella 0. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncologica 1994;33:409–413.
  • Wang C-J, Leung SW, Chen H-C, Sun L-M, Fang F-M, Huang E-Y, Hsiung C-Y, Changchien C-C, The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). International Journal of Radiation Oncology, Biology & Physics 1998;40:85–91.
  • Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis — where and how to look for it? Radiotherapy & Oncology 2002;64:131–140.
  • Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. International Journal of Radiation Oncology, Biology & Physics 2002;52:606–613.
  • Distel L, Neubauer S, Varon R, Holter W, Grabenbauer G. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Medical Pediatric Oncology 2003;41:44–48.
  • Lepock JR. Role of nuclear protein denaturation and aggregation in thermal radiosensitization. International Journal of Hyperthermia 2004;20:115–130.
  • Kampinga HH, Dynlacht JR, Dikomey E. Mechanism of radiosensitization by hyperthermia (>43°C) as derived from studies with DNA repair defective mutant cell lines. International Journal of Hyperthermia 2004:20: 131–139.
  • Dynlacht JR, Xu M, Pandita RK, Wetzel EA, Roti Roti JL. Effects of heat shock on the Mrell/Rad5O/Nbs1 complex in irradiated or unirradiated cells. International Journal of Hyperthermia 2004;20:144–156.
  • Xu M, Myerson RJ, Hunt C, Kumar S, Moros EG, Straube WL, Roti Roti JL. Transfection of human tumour cells with Mre 11 siRNA and the increase in radiation sensitivity and the reduction in heat-induced radiosensitization. International Journal of Hyperthermia 2004;20:157–162.
  • Myerson RJ, Roti Roti JL, Moros EG, Straube WL, Xu M. Modelling heat-induced radiosensitization: clinical implications. International Journal of Hyperthermia 2004;20:201–212.
  • Roti Roti JL. Introduction: Radiosensitization by hyperthermia. International Journal of Hyperthermia 2004;20:109–114.
  • Takahashi A, Ota I, Tamamoto T, Asakawa I, Nagata Y, Nakagawa H, Kondo N, Ohnishi K, Furusawa Y, Matsumoto H, Ohnishi T. p53-dependent hyperthermic enhancement of tumour growth inhibition by X-ray or carbon-ion beam irradiation. International Journal of Hyperthermia 2003;19: 145–153.
  • Vujaskovic Z, Song CW. Physiological mechanisms underlying heat-induced radiosensitization. International Journal of Hyperthermia 2004;20:163–174.
  • Stone HB. Thermal enhancement of radiation-induced leg contracture. International Journal of Radiatation Oncology, Biology & Physics 1990;18:595–602.
  • Haveman J, Smals OAG, Rodermond HM. Effects of hyperthermia on the rat bladder: a pre-clinical study on thermometry and functional damage after treatment. International Journal of Hyperthermia 2003;19:45–57.
  • Vujaskovic Z, Gillette SM, Powers BE, Stukel TA, Larue SM, Gillett EL, Borak TB, Scott RJ, Weiss J, Colacchio TA. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: neurologic and electrophysiologic study. International Journal of Radiatation Oncology, Biology & Physics 1996;34:125–131.
  • Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. International Journal of Radiation Oncology, Biology & Physics 1980;6:1507–1517 .
  • Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Amercian Journal of Clinical Oncology 1991;14:133–141.
  • Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. International Journal of Radiation Oncology, Biology & Physics 1993;28:163–169.
  • Overgaard J, Gonzalez Gonzalez D, Hulshof MC CM, Arcangeli G, Dahl 0, Mella 0, Bentzen SM, for the European Society for Hyperthermic Oncology. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995;345:540–543.
  • Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Journal of Radiation Oncology, Biology & Physics 1996;35:731–744.
  • Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P, Montesano A, Rubin P, Curran W, Delrowe J, Arastu H, Fu K, Moros E. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the Radiation Therapy Oncology Group. International Journal of Radiation Oncology, Biology & Physics 1996;34:1097–1104.
  • Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JDP, van Putten WLJ, Hart AAM, for the Dutch Deep Hyperthermia Group. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomized, multicentre trial. Lancet 2000;355:1119–1125.
  • Vasanthan A, Mitsumori M, Park JI-1, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, Tatsuzaki H, Tanaka Y, Hiraoka M. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the International Atomic Energy Agency. International Journal of Radiation Oncology, Biology & Physics 2005;61: 145–153.
  • Van Vulpen M, De Leeuw AAC, van de Kamer JB, Kroeze H, Boon TA, Warlim-Rodenhuis CC, Lagendijk H, Battermann JJ. Comparison of intra-luminal versus intra-tumoural temperature measurements in patients with locally advanced prostate cancer treated with the coaxial TEM system: report of a feasibility study. International Journal of Hyperthermia 2003;19:481–497.
  • Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncology 2002;3:487–497.
  • Del Regato JA. Magnus Strandqvist. International Journal of Radiation Oncology, Biology & Physics 1989;17:631–642.
  • Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncology 2003;4:529–536.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.